Drug Enforcement Administration June 7, 2017 – Federal Register Recent Federal Regulation Documents

Patricia A. Newton, M.D.; Order
Document Number: 2017-11798
Type: Notice
Date: 2017-06-07
Agency: Drug Enforcement Administration, Department of Justice
Emmanuel O. Nwaokocha, M.D.; Decision and Order
Document Number: 2017-11797
Type: Notice
Date: 2017-06-07
Agency: Drug Enforcement Administration, Department of Justice
Steven W. Easley, M.D.; Decision and Order
Document Number: 2017-11796
Type: Notice
Date: 2017-06-07
Agency: Drug Enforcement Administration, Department of Justice
Schedules of Controlled Substances: Placement of Acetyl Fentanyl Into Schedule I
Document Number: 2017-11795
Type: Rule
Date: 2017-06-07
Agency: Drug Enforcement Administration, Department of Justice
With the issuance of this final order, the Administrator of the Drug Enforcement Administration will maintain the placement of the substance acetyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- phenylacetamide), including its isomers, esters, ethers, salts, and salts of isomers, esters and ethers, in schedule I of the Controlled Substances Act. This scheduling action is pursuant to the Controlled Substances Act and is required in order for the United States to discharge its obligations under the Single Convention on Narcotic Drugs, 1961. This action continues to impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, import, export, engage in research or conduct instructional activities with, or possess), or propose to handle, acetyl fentanyl.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.